2014
DOI: 10.14737/journal.aavs/2014/2.1s.26.31
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Potential of a Candidate relA Deletion Mutant Vaccine of Mycobacterium Avium Subsp. Paratuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Mounting evidence shows it is also the causative agent of Crohn’s disease in humans [ 16 , 17 ]. The Map/relA mutant is one of three deletion mutants developed to test as a candidate vaccine for bovine paratuberculosis [ 11 , 13 , 18 , 19 ]. Ongoing studies have shown deletion of relA abrogates the capacity of Map to establish a persistent infection [ 11 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Mounting evidence shows it is also the causative agent of Crohn’s disease in humans [ 16 , 17 ]. The Map/relA mutant is one of three deletion mutants developed to test as a candidate vaccine for bovine paratuberculosis [ 11 , 13 , 18 , 19 ]. Ongoing studies have shown deletion of relA abrogates the capacity of Map to establish a persistent infection [ 11 ].…”
Section: Methodsmentioning
confidence: 99%
“…It is immune eliminated. A preliminary study has shown it has potential for use in immunotherapy and as a vaccine [ 19 ]. MMP is a 35 kD outer membrane protein with a potential for developing a subunit vaccine [ 9 ].…”
Section: Methodsmentioning
confidence: 99%